Catalent Cell & Gene Therapy is an industry-leading technology, development, and manufacturing partner for advanced therapeutics. A full-service partner for plasmid DNA, viral vectors, vaccines and autologous and allogeneic cell therapies, Catalent has a global network of small- and large-scale clinical and commercial manufacturing facilities in the U.S. and Europe. www.catalent.com
The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies. ARM promotes legislative, regulatory, reimbursement and manufacturing initiatives to advance this innovative and transformative sector, which includes cell therapies, gene therapies and tissue-based therapies. Early products to market have demonstrated profound, durable and potentially curative benefits that are already helping thousands of patients worldwide, many of whom have no other viable treatment options. Hundreds of additional product candidates contribute to a robust pipeline of potentially life-changing regenerative medicines and advanced therapies. In its 13-year history, ARM has become the voice of the sector, representing the interests of 400+ members worldwide, including small and large companies, academic research institutions, major medical centers and patient groups. To learn more about ARM or to become a member, visit www.alliancerm.org.
Sponsor the Program
Looking to gain extensive exposure to hundreds of top decision makers in the advanced therapies sector? Contact Laura Stringham at firstname.lastname@example.org to learn more about the benefits of supporting this year’s meeting.